Menu
GeneBe

TSPAN12

tetraspanin 12, the group of Tetraspanins

Basic information

Region (hg38): 7:120787319-120858402

Previous symbols: [ "TM4SF12" ]

Links

ENSG00000106025NCBI:23554OMIM:613138HGNC:21641Uniprot:O95859AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • exudative vitreoretinopathy 5 (Strong), mode of inheritance: AD
  • exudative vitreoretinopathy (Supportive), mode of inheritance: AD
  • exudative vitreoretinopathy 5 (Strong), mode of inheritance: AD
  • TSPAN12-related vitreoretinopathy (Definitive), mode of inheritance: Semidominant

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Exudative vitreoretinopathy 5; Retinal dysplasia and severe familial exudative vitreoretinopathyAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic20159111; 20159112; 20301326; 21334594; 21552475; 22427576

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TSPAN12 gene.

  • not provided (174 variants)
  • Exudative vitreoretinopathy 5 (57 variants)
  • Familial exudative vitreoretinopathy (7 variants)
  • Inborn genetic diseases (6 variants)
  • not specified (2 variants)
  • Retinal dystrophy (2 variants)
  • Atrophia bulborum hereditaria (1 variants)
  • TSPAN12-related condition (1 variants)
  • Persistent hyperplastic primary vitreous, autosomal recessive (1 variants)
  • Vitreoretinopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSPAN12 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
25
clinvar
2
clinvar
28
missense
2
clinvar
2
clinvar
83
clinvar
1
clinvar
2
clinvar
90
nonsense
5
clinvar
1
clinvar
6
start loss
1
clinvar
1
frameshift
7
clinvar
2
clinvar
9
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
3
clinvar
5
splice region
5
7
1
13
non coding
20
clinvar
12
clinvar
22
clinvar
54
Total 17 7 107 38 26

Highest pathogenic variant AF is 0.00000658

Variants in TSPAN12

This is a list of pathogenic ClinVar variants found in the TSPAN12 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-120787322-A-C Exudative vitreoretinopathy 5 Benign (Jan 12, 2018)358751
7-120787349-T-A Exudative vitreoretinopathy 5 Benign (Jan 13, 2018)358752
7-120787352-T-C Exudative vitreoretinopathy 5 Uncertain significance (Apr 27, 2017)909304
7-120787453-T-A Exudative vitreoretinopathy 5 Benign (Jan 13, 2018)358753
7-120787523-CAT-C Familial exudative vitreoretinopathy Likely benign (Jun 14, 2016)358754
7-120787594-C-T Exudative vitreoretinopathy 5 Benign (Jan 13, 2018)358755
7-120787705-G-C Exudative vitreoretinopathy 5 Uncertain significance (Jan 13, 2018)909305
7-120788039-G-C Exudative vitreoretinopathy 5 Uncertain significance (Jan 12, 2018)358756
7-120788258-T-A Exudative vitreoretinopathy 5 Benign (Jan 12, 2018)358757
7-120788263-C-T Exudative vitreoretinopathy 5 Uncertain significance (Jan 12, 2018)909306
7-120788466-A-G Exudative vitreoretinopathy 5 Uncertain significance (Jan 12, 2018)910278
7-120788488-G-T Exudative vitreoretinopathy 5 Uncertain significance (Jan 13, 2018)910279
7-120788489-G-T Exudative vitreoretinopathy 5 Uncertain significance (Jan 13, 2018)358758
7-120788552-A-G Exudative vitreoretinopathy 5 Likely benign (Jan 13, 2018)358759
7-120788553-G-A Exudative vitreoretinopathy 5 Benign (Sep 10, 2021)358760
7-120788593-TA-T Uncertain significance (Aug 21, 2022)2025627
7-120788597-ACTC-A Uncertain significance (Aug 10, 2022)1440864
7-120788601-C-T Likely benign (Aug 24, 2023)1948726
7-120788605-A-C Uncertain significance (Jan 25, 2024)2709979
7-120788613-G-T Uncertain significance (May 26, 2022)1900673
7-120788628-G-C Uncertain significance (Dec 01, 2021)1473031
7-120788633-C-T Uncertain significance (Nov 21, 2022)1462314
7-120788635-A-G Inborn genetic diseases Uncertain significance (Jul 12, 2023)944541
7-120788635-A-T Uncertain significance (May 20, 2020)1003287
7-120788640-T-C Likely benign (Nov 01, 2022)1565951

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TSPAN12protein_codingprotein_codingENST00000222747 771081
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6950.3051257350131257480.0000517
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7671311580.8280.000007422003
Missense in Polyphen3344.7370.73764563
Synonymous-0.04355655.61.010.00000268564
Loss of Function3.14317.00.1777.24e-7210

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003010.000300
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulator of cell surface receptor signal transduction. Plays a central role in retinal vascularization by regulating norrin (NDP) signal transduction. Acts in concert with norrin (NDP) to promote FZD4 multimerization and subsequent activation of FZD4, leading to promote accumulation of beta-catenin (CTNNB1) and stimulate LEF/TCF-mediated transcriptional programs. Suprisingly, it only activate the norrin (NDP)-dependent activation of FZD4, while it does not activate the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1) (By similarity). Acts as a regulator of membrane proteinases such as ADAM10 and MMP14/MT1-MMP. Activates ADAM10-dependent cleavage activity of amyloid precursor protein (APP). Activates MMP14/MT1-MMP-dependent cleavage activity. {ECO:0000250, ECO:0000269|PubMed:19211836, ECO:0000269|PubMed:19587294}.;
Disease
DISEASE: Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:20159111, ECO:0000269|PubMed:20159112, ECO:0000269|PubMed:22427576}. Note=The disease is caused by mutations affecting the gene represented in this entry. TSPAN12 dominant and recessive mutations have been identified in patients with exudative vitreoretinopathy. Patients with mutations in both alleles of TSPAN12 have severe exudative vitreoretinopathy or retinal dysplasia. These mutations appear to result in a milder phenotype in heterozygous mutation carriers (PubMed:22427576). {ECO:0000269|PubMed:22427576}.;

Recessive Scores

pRec
0.0790

Intolerance Scores

loftool
0.456
rvis_EVS
-0.16
rvis_percentile_EVS
41.64

Haploinsufficiency Scores

pHI
0.500
hipred
Y
hipred_score
0.644
ghis
0.522

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.398

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tspan12
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; hearing/vestibular/ear phenotype;

Gene ontology

Biological process
angiogenesis;cell surface receptor signaling pathway;retina layer formation;Wnt signaling pathway;regulation of angiogenesis
Cellular component
integral component of plasma membrane;membrane;integral component of membrane
Molecular function
protein binding;Wnt-activated receptor activity